| mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
IOX2 |
GDSC1000 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.002 |
0.9 |
| mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.002 |
0.9 |
| mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |